Ozempic side effects in women are, for the most part, the same side effects everyone gets: nausea, vomiting, diarrhea, constipation, and abdominal pain, worst during dose escalation and often easing as the body adapts. What differs is not a separate list of symptoms but a set of questions that come up specifically for women: contraception and pregnancy planning, changes to the menstrual cycle, PCOS and fertility, hair shedding after fast weight loss, gallbladder risk, and the long-term picture for muscle and bone. This article walks through each of those, sticking to what the evidence actually supports and flagging where it is thin.
What Ozempic is and why the side effects happen
Ozempic is the brand name for semaglutide, a once-weekly GLP-1 injection made by Novo Nordisk and approved by the FDA for type 2 diabetes. It is not approved for weight loss; that indication belongs to Wegovy, which is the same molecule at a higher maximum dose of 2.4 mg weekly. Ozempic is typically started at 0.25 mg for four weeks, then stepped up through 0.5 mg and 1 mg to a maximum of 2 mg.
Most of the common side effects trace back to a single mechanism. GLP-1 receptor agonists slow gastric emptying and act on appetite signaling in the brain and gut. Food sits in the stomach longer, fullness arrives sooner and lasts longer, and appetite drops. That same delayed gastric emptying is why nausea and early fullness are the symptoms people report most. For the full sex-neutral rundown, see our main guide to Ozempic side effects.
Ozempic side effects in women: the shared core profile
There is no separate female side-effect list in the labeling. The most common effects are gastrointestinal and are reported across sexes: nausea, vomiting, diarrhea, constipation, and abdominal pain. They are typically at their worst in the first days after starting and in the week or two after each dose increase, and they often settle as the body adapts to the dose.
| Side effect | What to expect | When it typically eases |
|---|---|---|
| Nausea | The most commonly reported effect; often tied to larger or higher-fat meals and to eating past fullness | Usually peaks in the days after a dose increase and settles over the following weeks at a steady dose |
| Vomiting | Less common than nausea; more likely at higher doses or after big meals | Generally improves as the dose is held steady; persistent vomiting is not something to push through |
| Diarrhea | Common, often intermittent rather than constant | Tends to ease after escalation; watch fluid intake while it lasts |
| Constipation | Common, and often driven partly by eating much less food and fiber | Frequently persists longer than nausea because the underlying cause is reduced intake |
| Abdominal pain | Usually mild cramping or a heavy, overfull feeling after meals | Generally eases with adaptation; severe or persistent pain is a red flag, not an adjustment symptom |
| Reduced appetite | An expected effect of the medication rather than a complication | Persists while on treatment; the practical issue is protein and nutrient intake, not the sensation itself |
Beyond the common effects, Ozempic carries a boxed warning about thyroid C-cell tumors seen in rodents, and it is contraindicated in anyone with a personal or family history of medullary thyroid carcinoma or MEN 2. Pancreatitis is a labeled risk. These apply regardless of sex.
Contraception and pregnancy: the most important conversation
This is the area where Ozempic side effects in women genuinely differ from the general profile, because it is about planning rather than symptoms.
Pregnancy
GLP-1 medicines are not recommended during pregnancy. Anyone who could become pregnant should discuss timing and contraception with a clinician before starting, and the labeling advises discontinuing the medication in advance of a planned pregnancy. The specific interval is a prescriber decision, not something to work out from an article, because it depends on the product and the individual situation. Our overview of GLP-1 medications and pregnancy covers what is and is not known.
Oral contraception
Because semaglutide delays gastric emptying and because rapid weight loss changes a lot of things at once, questions come up about whether oral contraceptive absorption is affected. Here is the honest position: this is a reasonable question to raise with a prescriber or pharmacist, and it is not a settled finding that Ozempic reduces the effectiveness of oral contraceptives. Do not change or stop any contraceptive method based on internet reading. Raise it at the appointment, ideally before the first injection, and let the clinician decide whether anything needs adjusting.
Menstrual cycle changes and PCOS
Reports of cycle changes on GLP-1 therapy are common in patient forums, and they are clinically plausible, but the likely driver is meaningful weight loss rather than a direct hormonal action of the drug. Body weight and body fat influence the reproductive axis, so substantial weight loss can shift cycle length, flow, or regularity in either direction. Framing matters here: this is a recognized consequence of weight change that clinicians discuss, not a proven pharmacological effect of semaglutide. Our piece on GLP-1 medications and women's hormones goes deeper.
The PCOS case deserves its own paragraph. In some people with polycystic ovary syndrome, weight loss is associated with more regular ovulation. The practical consequence is one that catches people off guard: someone who previously had difficulty conceiving may become more fertile, and an unplanned pregnancy becomes possible on a medication that is not recommended in pregnancy. That combination is exactly why contraception is worth discussing up front rather than after the fact. See GLP-1 medications for PCOS for the wider picture.
Hair shedding
Hair shedding after starting a GLP-1 is one of the most searched concerns among women, and the mechanism is fairly well understood. Rapid weight loss of any kind, from any method, can trigger telogen effluvium, a temporary shift that pushes more hairs than usual into the shedding phase. It typically shows up two to three months after the triggering event, and it is usually self-limiting.
The evidence points at the pace of weight loss and at nutrition, particularly protein and overall calorie adequacy, more than at the drug itself. That is a useful distinction, because pace and nutrition are things a person and their clinician can actually work on. Our article on GLP-1 hair loss causes covers what tends to help and when hair loss warrants a workup for something else, such as thyroid disease or iron deficiency.
Gallbladder problems
Gallbladder issues are a recognized concern with GLP-1 therapy, and the mechanism is not mysterious: rapid weight loss increases the risk of gallstones. Since gallstone disease is already more common in women than in men, this is worth knowing about specifically.
Symptoms to be aware of include pain in the upper-right abdomen, especially after fatty meals, pain that radiates to the right shoulder blade, fever, nausea with pain that does not settle, or yellowing of the skin or eyes. None of these are reasons to panic, but all of them are reasons to be seen rather than to wait it out. More detail is in our guide to GLP-1 medications and the gallbladder.
Muscle and bone
When weight comes off quickly, a meaningful share of what is lost can be lean mass rather than fat, particularly without adequate protein intake and resistance training. In the STEP-1 trial, semaglutide 2.4 mg produced a mean body-weight loss of about 14.9 percent over 68 weeks, which is a large change, and how much of that is fat versus lean tissue depends heavily on nutrition and training alongside the medication.
This matters for everyone, and it is raised particularly often for women around and after menopause, when bone density and muscle mass are already under pressure from other directions. The response is not to avoid effective treatment; it is to pair it with enough protein and with regular resistance training. Our overview of whether GLP-1 medications cause muscle loss unpacks the data.
When to contact a clinician urgently
Most side effects are the manageable, temporary kind. A small number are not. Seek urgent medical care for:
- Severe, persistent abdominal pain, especially pain that radiates through to the back, which can signal pancreatitis
- Persistent vomiting with signs of dehydration such as dizziness, very little urine, or a racing heartbeat
- Signs of gallbladder problems: upper-right abdominal pain, fever, or yellowing of the skin or eyes
- Signs of a severe allergic reaction such as swelling of the face, lips, or throat, trouble breathing, or a widespread rash
- Any symptom that is severe, is getting worse rather than better, or stops you from keeping fluids down
This article is educational and is not medical advice. It does not diagnose any condition and is not a substitute for care from a licensed clinician, who is the person who decides whether a medication is appropriate, at what dose, and for how long. Do not start, stop, or change any medication or contraceptive method based on what you read here. Bring your questions to your own prescriber.
Scientific References
3 sources- 1
Wilding JPH, Batterham RL, Calanna S, et al.
Once-Weekly Semaglutide in Adults with Overweight or Obesity
New England Journal of Medicine · 384(11) · 2021PMID: 33567185
PubMed - 2
Drucker DJ
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
Cell Metabolism · 27(4) · 2018PMID: 29617641
PubMed - 3
U.S. Food and Drug Administration
Prescribing information
U.S. Food and Drug Administration · 2026
References open in a new tab. Content is reviewed against peer-reviewed literature as part of our editorial policy.
About the author
Editor, Modern Weight Science
Claudiu Gheorghe is the editor of Modern Weight Science. He is not a physician. His role is to synthesize peer-reviewed studies, clinical-trial data, and FDA prescribing information into clear, plain-language explanations, and to make sure every factual claim on the site traces back to a cited source. Any decision about starting, changing, or stopping a medication belongs with a licensed clinician who knows your history.
Every claim is checked against peer-reviewed research through our review process and fact-checking policy.
Frequently Asked Questions
What are the side effects of Ozempic in women?
The side effects of Ozempic in women are the same core ones reported by everyone: nausea, vomiting, diarrhea, constipation, and abdominal pain, usually worst during dose escalation. Questions that come up specifically for women involve contraception, pregnancy planning, menstrual changes, PCOS, hair shedding, gallbladder risk, and muscle and bone health.
Does Ozempic affect your period?
Cycle changes are reported and are clinically plausible, but the likely driver is significant weight loss rather than a direct effect of semaglutide. Body weight influences the reproductive axis, so periods may become more or less regular. Persistent or unusual bleeding changes should always be assessed by a clinician.
Can Ozempic affect birth control?
Delayed gastric emptying and rapid weight loss raise reasonable questions about oral contraceptive absorption, but it is not established that Ozempic reduces contraceptive effectiveness. Raise it with your prescriber or pharmacist before starting rather than changing anything yourself. GLP-1 medicines are not recommended during pregnancy, so this conversation matters.
Does Ozempic cause hair loss in women?
Hair shedding reported on GLP-1 therapy is generally telogen effluvium, a temporary shedding phase triggered by rapid weight loss of any kind. Evidence links it more to the pace of weight loss and to nutrition, especially protein adequacy, than to semaglutide directly. It usually resolves as weight stabilizes.
Can you get pregnant on Ozempic?
Yes, and it can happen unexpectedly. Weight loss can improve ovulation in some people with PCOS, so someone who previously struggled to conceive may become more fertile. GLP-1 medicines are not recommended in pregnancy, and the labeling advises stopping in advance of a planned pregnancy at an interval your prescriber sets.
Does Ozempic cause gallbladder problems?
Gallbladder problems are a recognized concern with GLP-1 therapy, largely because rapid weight loss increases gallstone risk. Watch for upper-right abdominal pain, especially after fatty meals, pain radiating to the right shoulder blade, fever, or yellowing of the skin or eyes, and seek medical care promptly if they appear.
Continue learning
Where to read next
Not medical advice. This guide is for general education only. GLP-1 medications, dosing, and treatment suitability are decisions for you and a licensed clinician who knows your full medical history.